chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects after the 2nd dose). At the time of the report, VACCINATION COMPLICATION (Side effects after the 2nd dose) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Myalgia
Clinical narrative: slight cough high on her chest over the right breast; shortness of breath; hurt torso/hurt arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (hurt torso/hurt arm), COUGH (slight cough high on her chest over the right breast) and DYSPNOEA (shortness of breath) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 022B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VERAPAMIL, ATENOLOL, LOSARTAN, SIMVASTATIN, LEVOTHYROXINE, ALLOPURINOL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced MYALGIA (hurt torso/hurt arm). On an unknown date, the patient experienced COUGH (slight cough high on her chest over the right breast) and DYSPNOEA (shortness of breath). On 12-Jun-2021, MYALGIA (hurt torso/hurt arm) had resolved. At the time of the report, COUGH (slight cough high on her chest over the right breast) and DYSPNOEA (shortness of breath) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No treatment information was reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed dose/ We're out 7 weeks now/ missing the 42 day window; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed dose/ We're out 7 weeks now/ missing the 42 day window) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose/ We're out 7 weeks now/ missing the 42 day window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed dose/ We're out 7 weeks now/ missing the 42 day window) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Non significant follow up appended.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Bradyphrenia, Fatigue, Nasopharyngitis, Pyrexia
Clinical narrative: brain is slowed down; easily tired; fever/ temperature went up to 102/ body temperature has increased; cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), BRADYPHRENIA (brain is slowed down), PYREXIA (fever/ temperature went up to 102/ body temperature has increased) and FATIGUE (easily tired) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NASOPHARYNGITIS (cold). On 17-Apr-2021, the patient experienced PYREXIA (fever/ temperature went up to 102/ body temperature has increased). On an unknown date, the patient experienced BRADYPHRENIA (brain is slowed down) and FATIGUE (easily tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 17-Apr-2021, PYREXIA (fever/ temperature went up to 102/ body temperature has increased) had resolved. On 18-Apr-2021, NASOPHARYNGITIS (cold) had resolved. At the time of the report, BRADYPHRENIA (brain is slowed down) and FATIGUE (easily tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Apr-2021, Body temperature: 102 (High) His temperature lowered by 18Apr2021,His body temperature was 99 degrees from time to time. When he gets up in the morning, it's 98.5. In the afternoon, it can go up to 99.2. In the evening after 10 PM, it drops down to 98.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   After the first dose, he was perfectly fine,he felt nothing, After the second dose, the reaction was pretty bad. He stated it got better after 2 days. Initially he got fever on 16Apr2021 and cold. This has been going on for 2 months. He still feels like he is easily tired.Prior togetting vaccinated, his body temperature was 97.5-98 degrees during the day. He states his body temperature has increased after getting the vaccine, and his brain is slowed down.   No  Concomitant medications were provided
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: A patient received his first dose of Moderna Covid-19 vaccine in Feb2021, which exceeded thelength of vaccination for second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (A patient received his first dose of Moderna Covid-19 vaccine in Feb2021, which exceeded thelength of vaccination for second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (A patient received his first dose of Moderna Covid-19 vaccine in Feb2021, which exceeded thelength of vaccination for second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (A patient received his first dose of Moderna Covid-19 vaccine in Feb2021, which exceeded thelength of vaccination for second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.   Reporter did not allow further contact
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Extra dose administered, Headache, Myalgia, Nausea
Clinical narrative: Received both dose of Pfizer vaccine and also received the Moderna Vaccine; off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine); chills; ore arm/pain but not extremely sore and couldn't sleep on it; Slight throbbing behind the forehead and eyes but it is not a migraine; nausea; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Received both dose of Pfizer vaccine and also received the Moderna Vaccine), OFF LABEL USE (off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine)), CHILLS (chills), MYALGIA (ore arm/pain but not extremely sore and couldn't sleep on it) and HEADACHE (Slight throbbing behind the forehead and eyes but it is not a migraine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 immunisation: Pfizer (Receive both doses of Pfizer vaccine in 2021.).   On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced EXTRA DOSE ADMINISTERED (Received both dose of Pfizer vaccine and also received the Moderna Vaccine), OFF LABEL USE (off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine)), CHILLS (chills), MYALGIA (ore arm/pain but not extremely sore and couldn't sleep on it), HEADACHE (Slight throbbing behind the forehead and eyes but it is not a migraine) and NAUSEA (nausea). On 17-Jun-2021, NAUSEA (nausea) had resolved. At the time of the report, EXTRA DOSE ADMINISTERED (Received both dose of Pfizer vaccine and also received the Moderna Vaccine), OFF LABEL USE (off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine)), CHILLS (chills), MYALGIA (ore arm/pain but not extremely sore and couldn't sleep on it) and HEADACHE (Slight throbbing behind the forehead and eyes but it is not a migraine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   The patient administered both doses of Pfizer vaccine in the year 2021 (was not sure of the exact month). The patient then administered Moderna vaccine as a booster shot.  No concomitant medication were reported. No treatment information was reported
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Received both dose of Pfizer vaccine and also received the Moderna Vaccine; off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine); chills; ore arm/pain but not extremely sore and couldn't sleep on it; Slight throbbing behind the forehead and eyes but it is not a migraine; nausea; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Received both dose of Pfizer vaccine and also received the Moderna Vaccine), OFF LABEL USE (off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine)), CHILLS (chills), MYALGIA (ore arm/pain but not extremely sore and couldn't sleep on it) and HEADACHE (Slight throbbing behind the forehead and eyes but it is not a migraine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 immunisation: Pfizer (Receive both doses of Pfizer vaccine in 2021.).   On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced EXTRA DOSE ADMINISTERED (Received both dose of Pfizer vaccine and also received the Moderna Vaccine), OFF LABEL USE (off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine)), CHILLS (chills), MYALGIA (ore arm/pain but not extremely sore and couldn't sleep on it), HEADACHE (Slight throbbing behind the forehead and eyes but it is not a migraine) and NAUSEA (nausea). On 17-Jun-2021, NAUSEA (nausea) had resolved. At the time of the report, EXTRA DOSE ADMINISTERED (Received both dose of Pfizer vaccine and also received the Moderna Vaccine), OFF LABEL USE (off label use( first 2 pfizer vaccine and 3rd one Moderna vaccine)), CHILLS (chills), MYALGIA (ore arm/pain but not extremely sore and couldn't sleep on it) and HEADACHE (Slight throbbing behind the forehead and eyes but it is not a migraine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   The patient administered both doses of Pfizer vaccine in the year 2021 (was not sure of the exact month). The patient then administered Moderna vaccine as a booster shot.  No concomitant medication were reported. No treatment information was reported
Age: 42.0
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Pyrexia
Clinical narrative: fever; Breathing problems; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Breathing problems) and PYREXIA (fever) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Allergy, Smell loss (two years) and Taste loss (two years). Concomitant products included ALBUTEROL SULFATE and FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPNOEA (Breathing problems). On 08-Mar-2021, the patient experienced PYREXIA (fever). At the time of the report, DYSPNOEA (Breathing problems) and PYREXIA (fever) outcome was unknown.            Treatment medication included inhalers  Action taken with mRNA-1273 Moderna vaccine was Not Applicable   This case was linked to MOD-2021-038166 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.   On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication was reported.  It was not reported if the patient was received any corrective treatment for the event.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Rash
Clinical narrative: trouble breathing; rash; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (trouble breathing) and RASH (rash) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product CODEINE for an unknown indication.    Concurrent medical conditions included Blood pressure high, Nose bleeds, Venous insufficiency (in both legs), Disorder ear (an ears disease that cause her to feel vertigo) and Allergy to chemicals (13 allergies to medicines (no further details provided)).   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and CODEINE (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (trouble breathing) and RASH (rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of 1 dosage form and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Rash, at a dose of 1 dosage form. At the time of the report, DYSPNOEA (trouble breathing) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter mentioned during call that patient was in the hospital (when she received the first dose of the vaccine) that her trouble breathing was from Codeine not that she had an anaphylactic shock.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: broke out; rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (broke out) and RASH (rash) in a 20-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (broke out) and RASH (rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at a dose of 1 dosage form. At the time of the report, URTICARIA (broke out) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No details provided regarding Concomitant Medications.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient about to receive second vaccine 84day after first vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient about to receive second vaccine 84day after first vaccine) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient about to receive second vaccine 84day after first vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient about to receive second vaccine 84day after first vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported. The treatment information was not provided.  The patient consulted pharmacist for second dose of Moderna COVID-19 Vaccine .Pharmacist wanted to confirm if it was possible to give second dose as it was beyond the window period.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (symptoms). At the time of the report, VACCINATION COMPLICATION (symptoms) outcome was unknown.            No treatment information was reported
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: Sore arm; Upset stomach; Diarrhea; Red  burning eyes; Red painful swollen eye lid; Painful swollen eye lid; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Upset stomach), DIARRHOEA (Diarrhea), OCULAR HYPERAEMIA (Red  burning eyes) and SWELLING OF EYELID (Red painful swollen eye lid) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect products included non-company products TASIMELTEON (HETLIOZ) capsule for Circadian rhythm sleep disorder and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for Asthma.    The patient's past medical history included Victim of child abuse and Developmental disturbance (Patient missed social steps). Previously administered products included for Product used for unknown indication: Depakote, Biaxin, Dynapen, Codeine, Erythromycin, Abilify and Keflex. Past adverse reactions to the above products included Drug allergy with Abilify, Biaxin, Codeine, Depakote, Dynapen, Erythromycin and Keflex. Concurrent medical conditions included Attention deficit hyperactivity disorder (Patient stated the condition as predominantly inattentive type), Major depressive disorder (Patient stated the condition as recurrent, moderate), Post-traumatic stress disorder, Anxiety and Asthma. Concomitant products included RANITIDINE HYDROCHLORIDE (ZANTAC), BECLOMETASONE DIPROPIONATE (QNASL), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), ALPRAZOLAM (XANAX), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and ESZOPICLONE (LUNESTA) for an unknown indication.   In 2015, the patient started TASIMELTEON (HETLIOZ) (Oral) 20 milligram once a day. On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) (unknown route) at an unspecified dose. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). 14-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach), DIARRHOEA (Diarrhea), OCULAR HYPERAEMIA (Red  burning eyes), SWELLING OF EYELID (Red painful swollen eye lid) and EYELID PAIN (Painful swollen eye lid). At the time of the report, PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Upset stomach), OCULAR HYPERAEMIA (Red  burning eyes), SWELLING OF EYELID (Red painful swollen eye lid) and EYELID PAIN (Painful swollen eye lid) had not resolved and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported that she took treatment medication along with Hetlioz. Patient also reported that episodes of not sleeping well after taking Hetlioz resulted in waking with burning eyes.
Sex: M
Vaccine: COVID19
Symptoms: Skin weeping, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Feels like weeping under patch; Itchy looks like sun burn; The skin at application is red; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WEEPING (Feels like weeping under patch), VACCINATION SITE PRURITUS (Itchy looks like sun burn) and VACCINATION SITE ERYTHEMA (The skin at application is red) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN WEEPING (Feels like weeping under patch), VACCINATION SITE PRURITUS (Itchy looks like sun burn) and VACCINATION SITE ERYTHEMA (The skin at application is red). At the time of the report, SKIN WEEPING (Feels like weeping under patch), VACCINATION SITE PRURITUS (Itchy looks like sun burn) and VACCINATION SITE ERYTHEMA (The skin at application is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included "Rhodes Bup", and pain patch.  Per report, the patient used a pain patch without complaints prior to receiving his vaccination and the subsequent skin reactions.  Treatment information was not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Significant FU - Patient Initials was updated.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash, Rash pruritic, Vaccination site discolouration
Clinical narrative: Blistering rash; One hell of a rash / irritating rash; Injection site has become dark purplish spot; Itching so bad all around the rash area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Injection site has become dark purplish spot), RASH PRURITIC (Itching so bad all around the rash area), BLISTER (Blistering rash) and RASH (One hell of a rash / irritating rash) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Aspirin.).    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jun-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Injection site has become dark purplish spot), RASH PRURITIC (Itching so bad all around the rash area) and RASH (One hell of a rash / irritating rash). On an unknown date, the patient experienced BLISTER (Blistering rash). At the time of the report, VACCINATION SITE DISCOLOURATION (Injection site has become dark purplish spot), RASH PRURITIC (Itching so bad all around the rash area), BLISTER (Blistering rash) and RASH (One hell of a rash / irritating rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. No treatment medications were reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up received on 18-Jun-2021 contains no new information (NNI)
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Gait disturbance, Induration, Muscle tightness, Pain
Clinical narrative: Entire leg turning black and blue; Tender to touch and cannot put pressure on it or bend the leg/Hip to ankle tenderness; Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.; Right leg swells Hard as a rock; Right leg tight; Right leg tight and ache getting worse and pain intensifies; Trouble walking; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (Right leg tight), PAIN (Right leg tight and ache getting worse and pain intensifies), PERIPHERAL SWELLING (Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.), INDURATION (Right leg swells Hard as a rock) and CONTUSION (Entire leg turning black and blue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031BZ1A and 036AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Lipitor), Latex allergy and Stroke since 27-Jun-2017. Concomitant products included WARFARIN SODIUM (COUMADIN) from 29-Jun-2017 to an unknown date and ROSUVASTATIN from 29-Jun-2017 to an unknown date for Stroke.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MUSCLE TIGHTNESS (Right leg tight), PAIN (Right leg tight and ache getting worse and pain intensifies) and GAIT DISTURBANCE (Trouble walking). On 16-Apr-2021, the patient experienced PERIPHERAL SWELLING (Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.) and INDURATION (Right leg swells Hard as a rock). On 22-Apr-2021, the patient experienced CONTUSION (Entire leg turning black and blue) and TENDERNESS (Tender to touch and cannot put pressure on it or bend the leg/Hip to ankle tenderness). At the time of the report, MUSCLE TIGHTNESS (Right leg tight), INDURATION (Right leg swells Hard as a rock), TENDERNESS (Tender to touch and cannot put pressure on it or bend the leg/Hip to ankle tenderness) and GAIT DISTURBANCE (Trouble walking) had not resolved and PAIN (Right leg tight and ache getting worse and pain intensifies), PERIPHERAL SWELLING (Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.) and CONTUSION (Entire leg turning black and blue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Ultrasound Doppler: unknown (Inconclusive) unknown.         Patient reports that he continued Ice elevation and rest as treatment. He reported that he visited Orthopaedic specialist twice.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-090461 (Patient Link).
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Tenderness, Ultrasound Doppler
Clinical narrative: Entire leg turning black and blue; Tender to touch and cannot put pressure on it or bend the leg/Hip to ankle tenderness; Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.; Right leg swells Hard as a rock; Right leg tight; Right leg tight and ache getting worse and pain intensifies; Trouble walking; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (Right leg tight), PAIN (Right leg tight and ache getting worse and pain intensifies), PERIPHERAL SWELLING (Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.), INDURATION (Right leg swells Hard as a rock) and CONTUSION (Entire leg turning black and blue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031BZ1A and 036AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Lipitor), Latex allergy and Stroke since 27-Jun-2017. Concomitant products included WARFARIN SODIUM (COUMADIN) from 29-Jun-2017 to an unknown date and ROSUVASTATIN from 29-Jun-2017 to an unknown date for Stroke.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MUSCLE TIGHTNESS (Right leg tight), PAIN (Right leg tight and ache getting worse and pain intensifies) and GAIT DISTURBANCE (Trouble walking). On 16-Apr-2021, the patient experienced PERIPHERAL SWELLING (Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.) and INDURATION (Right leg swells Hard as a rock). On 22-Apr-2021, the patient experienced CONTUSION (Entire leg turning black and blue) and TENDERNESS (Tender to touch and cannot put pressure on it or bend the leg/Hip to ankle tenderness). At the time of the report, MUSCLE TIGHTNESS (Right leg tight), INDURATION (Right leg swells Hard as a rock), TENDERNESS (Tender to touch and cannot put pressure on it or bend the leg/Hip to ankle tenderness) and GAIT DISTURBANCE (Trouble walking) had not resolved and PAIN (Right leg tight and ache getting worse and pain intensifies), PERIPHERAL SWELLING (Right leg swells Hard as a rock. Tender to touch and cannot put pressure on it or bend the leg.) and CONTUSION (Entire leg turning black and blue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Ultrasound Doppler: unknown (Inconclusive) unknown.         Patient reports that he continued Ice elevation and rest as treatment. He reported that he visited Orthopaedic specialist twice.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-090461 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Memory impairment
Clinical narrative: Problems with remembering now; Lethargy; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (Problems with remembering now) and LETHARGY (Lethargy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Meningitis and Infection (Had an infection before 1st dose and took medicine.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MEMORY IMPAIRMENT (Problems with remembering now) and LETHARGY (Lethargy). At the time of the report, MEMORY IMPAIRMENT (Problems with remembering now) and LETHARGY (Lethargy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-072608, MOD-2021-226822 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-072608:Same reporter (wife case) MOD-2021-226822:Dose 2 case
Sex: U
Vaccine: COVID19
Symptoms: Urinary tract disorder
Clinical narrative: urinary side effects; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT DISORDER (urinary side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT DISORDER (urinary side effects). At the time of the report, URINARY TRACT DISORDER (urinary side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter.  Treatment information was not provided.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included INSULIN, LISINOPRIL, LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL), AZELASTINE and FAMOTIDINE (PEPCID AC) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-256801 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: follow up received on 13-JUL-2021 contains concomitant medications
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Past 42 days since fisrt dose of vaccine/missed second dose/Inappropriate schedule of vaccine administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 42 days since fisrt dose of vaccine/missed second dose/Inappropriate schedule of vaccine administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 42 days since fisrt dose of vaccine/missed second dose/Inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 42 days since fisrt dose of vaccine/missed second dose/Inappropriate schedule of vaccine administered) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous floaters, Vomiting
Clinical narrative: floaters in right eye; Threw up; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (floaters in right eye) and VOMITING (Threw up) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003021A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for Diabetes.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced VITREOUS FLOATERS (floaters in right eye) and VOMITING (Threw up). At the time of the report, VITREOUS FLOATERS (floaters in right eye) and VOMITING (Threw up) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Rib fracture
Clinical narrative: Not able to make their appointment for the second dose of the Moderna COVID-19 vaccine.; Suffered broken ribs after he was kicked in the ribs by a cow on their farm; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not able to make their appointment for the second dose of the Moderna COVID-19 vaccine.) and RIB FRACTURE (Suffered broken ribs after he was kicked in the ribs by a cow on their farm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not able to make their appointment for the second dose of the Moderna COVID-19 vaccine.) and RIB FRACTURE (Suffered broken ribs after he was kicked in the ribs by a cow on their farm). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not able to make their appointment for the second dose of the Moderna COVID-19 vaccine.) had resolved and RIB FRACTURE (Suffered broken ribs after he was kicked in the ribs by a cow on their farm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product administration interrupted
Clinical narrative: trying to find an appointment for my 2nd vaccine that is past due; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (trying to find an appointment for my 2nd vaccine that is past due) and PRODUCT AVAILABILITY ISSUE (trying to find an appointment for my 2nd vaccine that is past due) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (trying to find an appointment for my 2nd vaccine that is past due) and PRODUCT AVAILABILITY ISSUE (trying to find an appointment for my 2nd vaccine that is past due). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (trying to find an appointment for my 2nd vaccine that is past due) and PRODUCT AVAILABILITY ISSUE (trying to find an appointment for my 2nd vaccine that is past due) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information, if any, was not provided by the reporter.  Treatment information, if any, was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Pyrexia
Clinical narrative: Weakness generalised; Dizziness aggravated; tiredness; fever; This spontaneous case was reported by a health care professional and describes the occurrence of ASTHENIA (Weakness generalised), DIZZINESS (Dizziness aggravated), FATIGUE (tiredness) and PYREXIA ( fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced FATIGUE (tiredness) and PYREXIA ( fever). On 24-Feb-2021, the patient experienced ASTHENIA (Weakness generalised) and DIZZINESS (Dizziness aggravated). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. On 21-Feb-2021, FATIGUE (tiredness) and PYREXIA ( fever) had resolved. At the time of the report, ASTHENIA (Weakness generalised) and DIZZINESS (Dizziness aggravated) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient went to emergency visit. Patient was not taking any other concomitant medications. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to MOD-2021-039630 (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Rash on back , buttocks, legs/Itchy and red rash; Itchy and red rash; Rash every 72 hours; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash on back , buttocks, legs/Itchy and red rash), RASH ERYTHEMATOUS (Itchy and red rash) and RASH (Rash every 72 hours) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Rash on back , buttocks, legs/Itchy and red rash), RASH ERYTHEMATOUS (Itchy and red rash) and RASH (Rash every 72 hours). At the time of the report, RASH PRURITIC (Rash on back , buttocks, legs/Itchy and red rash), RASH ERYTHEMATOUS (Itchy and red rash) and RASH (Rash every 72 hours) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Pain in extremity, Somnolence
Clinical narrative: Sore arm; Falls asleep, sleeps 4 to 5 hours; Falls asleep; Tiredness/ feeling exhausted/ fatigue that is immense and overtakes her body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), SOMNOLENCE (Falls asleep, sleeps 4 to 5 hours), INSOMNIA (Falls asleep) and FATIGUE (Tiredness/ feeling exhausted/ fatigue that is immense and overtakes her body) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 036A21A) for COVID-19 vaccination.     The patient's past medical history included Lymph node excision (Ten lymph nodes were taken out due to cancer.). Concurrent medical conditions included Cancer.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), SOMNOLENCE (Falls asleep, sleeps 4 to 5 hours), INSOMNIA (Falls asleep) and FATIGUE (Tiredness/ feeling exhausted/ fatigue that is immense and overtakes her body). At the time of the report, PAIN IN EXTREMITY (Sore arm), SOMNOLENCE (Falls asleep, sleeps 4 to 5 hours) and FATIGUE (Tiredness/ feeling exhausted/ fatigue that is immense and overtakes her body) had resolved and INSOMNIA (Falls asleep) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Patient experienced sore arm felt like having a flu shot. No treatment information was provided.      Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up information received on 12-Jul-2021 updated events outcome to resolved.; Sender's Comments:
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Horrible headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Horrible headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Horrible headache). At the time of the report, HEADACHE (Horrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Face is swollen after getting my second shot; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face is swollen after getting my second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Face is swollen after getting my second shot). At the time of the report, SWELLING FACE (Face is swollen after getting my second shot) outcome was unknown.            No concomitant medications was provided by the reporter.  No treatment drug details was provided.